ROTOP Pharmaka is a leading pharmaceutical company that manufactures cGMP compliant radiopharmaceuticals for Theranostics in the fields of nuclear medicine and molecular imaging and distributes them in over 40 countries worldwide. The ROTOP brand stands for quality and reliability. We attach great importance to proximity to our customers and optimal services for the best possible individual solutions.
We have over 20 years of experience in developing, manufacturing, licensing and distributing sterile cold kits for radiolabelled drugs and are continuously expanding the product portfolio together with our strategic partners.
Active ingredients, sterile lyophilizates and reagents are produced strictly according to the rules of current Good Manufacturing Practice (cGMP). Our comprehensive Quality Assurance unit is supervising our production, contract manufacturing and distribution.
Our Executive Team
Dr. Antje Sterger
COO (Chief Operations Officer)
Anke Burmester
VP Sales DACH-Region
Anja Schulze
VP Controlling, Finance & HR
Dr. Astrid Gräfe
VP Facility Development
Anne Zimmer
VP Quality Assurance
Dr. Susan Hoppmann
VP Clinical Development & Medical Affairs
Jens Junker
CEO & Managing Partner
Dr. Eik Schiller
VP Pharmaceutical Development
Dr. Felix Roschke
VP CDMO Services
Franziska Klein
VP Regulatory Affairs
Sustainability at ROTOP
For us at ROTOP patient safety is always our top priority. Furthermore, we are aware that as our company grows, our responsibility for sustainability and our environment increases. In order to meet this responsibility, we created a defined project team in early 2022 to develop a sustainability concept for ROTOP.
